65400 Federal Register / Vol. 79, No. 213 / Tuesday, November 4, 2014 / Notices 

Leroy A. Richardson, 

Chief, Information Collection Review Office, 

Office of Scientific Integrity, Office of the 

Associate Director for Science, Office of the 

Director, Centers for Disease Control and 

Prevention. 

[FR Doc. 2014–26132 Filed 11–3–14; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee on Breast Cancer 

in Young Women (ACBCYW) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC), 

announces the following meeting of the 

aforementioned committee: 

Times and Dates: 9:00 a.m.–5:30 p.m. EST, 

December 4, 2014; 8:00 a.m.–12:00 p.m. EST, 

December 5, 2014. 

Place: CDC, 4770 Buford Highway, 

Chamblee Building 107 1B/1C, Atlanta, 

Georgia 30341. 

This meeting is also accessible by 

teleconference and web access. 

Teleconference and web access login 

information is as follows: 

Toll-Free Telephone: 1–800–621–3587, 

Participant passcode: 9679129. There is also 

a toll number for anyone outside of the USA: 

TOLL NUMBER: 1–517–308–9263, 

Participant passcode: 96791NET 

CONFERENCE AND WEB URL: For 

December 4, 2014: https://

www.mymeetings.com/nc/join/ Conference 

number: PW9240020, Audience passcode: 

9679129. 

For December 5, 2014: https://

www.mymeetings.com/nc/join/ Conference 

number: PW9240028, Audience passcode: 

9679129. 

Participants can join the event directly at: 

https://www.mymeetings.com/nc/

join.php?i=PW9240020&p=9679129&t=c. 

Status: Open to the public, limited only by 

the space and phone lines available. 

Purpose: The committee provides advice 

and guidance to the Secretary, HHS; the 

Assistant Secretary for Health; and the 

Director, CDC, regarding the formative 

research, development, implementation and 

evaluation of evidence-based activities 

designed to prevent breast cancer 

(particularly among those at heightened risk) 

and promote the early detection and support 

of young women who develop the disease. 

The advice provided by the Committee will 

assist in ensuring scientific quality, 

timeliness, utility, and dissemination of 

credible appropriate messages and resource 

materials. 

Matters for Discussion: The agenda will 

include discussions on the current and 

emerging topics related to breast cancer in 

young women. These may include public 

health communication, breast cancer in 

young women digital and social media 

campaigns, and CDC updates. Topics will 

address efforts increase awareness around 

breast cancer risk, breast health, symptoms, 

diagnosis, and treatment of breast cancer in 

young women. 

Agenda items are subject to change as 

priorities dictate. 

Online Registration Required: In order to 

expedite the security clearance process 

required for entry into a Federal building, all 

ACBCYW attendees must register for the 

meeting online at least 7 days in advance at 

http://www.cdc.gov/cancer/breast/what_cdc_

is_doing/meetings.htm. Please complete all 

the required fields before submitting your 

registration and submit no later than 

November 28, 2014. Each meeting day, 

attendees must provide CDC staff and 

security with driver’s license/state issued ID, 

or passport. 

Contact Person for More Information: 

Temeika L. Fairley, Ph.D., Designated Federal 

Officer, National Center for Chronic Disease 

Prevention and Health Promotion, CDC, 5770 

Buford Hwy. NE., Mailstop K52, Atlanta, 

Georgia 30341, Telephone (770) 488–4518, 

Fax (770) 488–4760. Email: acbcyw@cdc.gov. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention, and Agency for Toxic Substances 

and Disease Registry. 

Claudette Grant, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 2014–26082 Filed 11–3–14; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Board of Scientific Counselors, Office 

of Infectious Diseases (BSC, OID); 

Notice of Meeting 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC), 

announces the following meeting of the 

aforementioned committee: 

Time and Date: 10:00–11:00 a.m. EST, 

November 20, 2014. 

Place: Teleconference. 

Status: The meeting is open to the public; 

the toll free dial in number is 1–877–951– 

7311 with a pass code of 1588067. 

Purpose: The BSC, OID, provides advice 

and guidance to the Secretary, Department of 

Health and Human Services; the Director, 

CDC; the Director, OID; and the Directors of 

the National Center for Immunization and 

Respiratory Diseases, the National Center for 

Emerging and Zoonotic Infectious Diseases, 

and the National Center for HIV/AIDS, Viral 

Hepatitis, STD, and TB Prevention, CDC, in 

the following areas: strategies, goals, and 

priorities for programs; research within the 

national centers; and overall strategic 

direction and focus of OID and the national 

centers. 

Matters for Discussion: Discussions will 

focus on current responses and national 

center priorities. 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: 

Robin Moseley, M.A.T., Designated Federal 

Officer, OID, CDC, 1600 Clifton Road NE., 

Mailstop D10, Atlanta, Georgia 30333, 

Telephone: (404) 639–4461. 

The Director, Management Analysis and 

Services Office has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Claudette Grant, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 2014–26083 Filed 11–3–14; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–10527] 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, HHS. 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information (including each proposed 

extension or reinstatement of an existing 

collection of information) and to allow 

60 days for public comment on the 

proposed action. Interested persons are 

invited to send comments regarding our 

burden estimates or any other aspect of 

this collection of information, including 

any of the following subjects: (1) The 

necessity and utility of the proposed 

information collection for the proper 

performance of the agency’s functions; 

(2) the accuracy of the estimated 

burden; (3) ways to enhance the quality, 

utility, and clarity of the information to 


rmajette on DSK3VPTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 213 / Tuesday, November 4, 2014 / Notices 65401 

be collected; and (4) the use of 

automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

DATES: Comments must be received by 

January 5, 2015. 

ADDRESSES: When commenting, please 

reference the document identifier or 

OMB control number (OCN). To be 

assured consideration, comments and 

recommendations must be submitted in 

any one of the following ways: 

1. Electronically. You may send your 

comments electronically to http://

www.regulations.gov. Follow the 

instructions for ‘‘Comment or 

Submission’’ or ‘‘More Search Options’’ 

to find the information collection 

document(s) that are accepting 

comments. 

2. By regular mail. You may mail 

written comments to the following 

address: CMS, Office of Strategic 

Operations and Regulatory Affairs, 

Division of Regulations Development, 

Attention: Document Identifier/OMB 

Control Number llll, Room C4–26– 

05, 7500 Security Boulevard, Baltimore, 

Maryland 21244–1850. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, you may make your request 

using one of following: 

1. Access CMS’ Web site address at 

http://www.cms.hhs.gov/

PaperworkReductionActof1995. 

2. Email your request, including your 

address, phone number, OMB number, 

and CMS document identifier, to 

Paperwork@cms.hhs.gov. 

3. Call the Reports Clearance Office at 

(410) 786–1326. 

FOR FURTHER INFORMATION CONTACT: 

Reports Clearance Office at (410) 786– 

1326. 

SUPPLEMENTARY INFORMATION: 

Contents 

This notice sets out a summary of the 

use and burden associated with the 

following information collections. More 

detailed information can be found in 

each collection’s supporting statement 

and associated materials (see 

ADDRESSES). 

CMS–10527 Annual Eligibility 

Redetermination, Product 

Discontinuation and Renewal Notices 

Under the PRA (44 U.S.C. 3501– 

3520), federal agencies must obtain 

approval from the Office of Management 

and Budget (OMB) for each collection of 

information they conduct or sponsor. 

The term ‘‘collection of information’’ is 

defined in 44 U.S.C. 3502(3) and 5 CFR 

1320.3(c) and includes agency requests 

or requirements that members of the 

public submit reports, keep records, or 

provide information to a third party. 

Section 3506(c)(2)(A) of the PRA 

requires federal agencies to publish a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, before 

submitting the collection to OMB for 

approval. To comply with this 

requirement, CMS is publishing this 

notice. 

Information Collection 

1. Type of Information Collection 

Request: Extension of a currently 

approved collection; Title of 

Information Collection: Annual 

Eligibility Redetermination, Product 

Discontinuation and Renewal Notices; 

Use: Section 1411(f)(1)(B) of the 

Affordable Care Act directs the 

Secretary of Health and Human Services 

(the Secretary) to establish procedures 

to redetermine the eligibility of 

individuals on a periodic basis in 

appropriate circumstances. Section 

1321(a) of the Affordable Care Act 

provides authority for the Secretary to 

establish standards and regulations to 

implement the statutory requirements 

related to Exchanges, QHPs and other 

components of title I of the Affordable 

Care Act. Under section 2703 of the PHS 

Act, as added by the Affordable Care 

Act, and sections 2712 and 2741 of the 

PHS Act, enacted by the Health 

Insurance Portability and 

Accountability Act of 1996, health 

insurance issuers in the group and 

individual markets must guarantee the 

renewability of coverage unless an 

exception applies. 

The final rule ‘‘Patient Protection and 

Affordable Care Act; Annual Eligibility 

Redeterminations for Exchange 

Participation and Insurance 

Affordability Programs; Health 

Insurance Issuer Standards Under the 

Affordable Care Act, Including 

Standards Related to Exchanges’’ (79 FR 

52994), provides that an Exchange may 

choose to conduct the annual 

redetermination process for a plan year 

(1) in accordance with the existing 

procedures described in 45 CFR 

155.335; (2) in accordance with 

procedures described in guidance 

issued by the Secretary for the coverage 

year; or (3) using an alternative 

proposed by the Exchange and approved 

by the Secretary. The guidance 

document ‘‘Guidance on Annual 

Redeterminations for Coverage for 

2015’’ contains the procedures that the 

Secretary is specifying for the 2015 

coverage year, as noted in (2) above. 

These procedures will be adopted by the 

Federally-facilitated Exchange. Under 

this option, the Exchange will provide 

three notices. These notices may be 

combined. 

The final rule also amends the 

requirements for product renewal and 

re-enrollment (or non-renewal) notices 

to be sent by Qualified Health Plan 

(QHP) issuers in the Exchanges and 

specifies content for these notices. The 

accompanying guidance document 

‘‘Form and Manner of Notices When 

Discontinuing or Renewing a Product in 

the Group or Individual Market’’ 

provides standard notices for product 

discontinuation and renewal to be sent 

by issuers of individual market QHPs 

and issuers in the individual market. 

Issuers in the small group market may 

use the draft Federal standard small 

group notices released in the June 26, 

2014 bulletin ‘‘Draft Standard Notices 

When Discontinuing or Renewing a 

Product in the Small Group or 

Individual Market,’’ or any forms of the 

notice otherwise permitted by 

applicable laws and regulations. States 

that are enforcing the Affordable Care 

Act may develop their own standard 

notices, for product discontinuances, 

renewals, or both, provided the Statedeveloped notices are at least as 

protective as the Federal standard 

notices. Form Number: CMS–10527; 

Frequency: Annual; Affected Public: 

Private Sector, State Governments; 

Number of Respondents: 2,945; Number 

of Responses: 12,224; Total Annual 

Hours: 149,186. (For policy questions 

regarding this collection, contact Usree 

Bandyopadhyay at 410–786–6650.) 

Dated: October 29, 2014. 

Martique Jones, 

Director, Regulations Development Group, 

Office of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 2014–26041 Filed 11–3–14; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifiers: CMS–10522] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 


rmajette on DSK3VPTVN1PROD with NOTICES